» Articles » PMID: 24837585

Temporal Trends in Marijuana Attitudes, Availability and Use in Colorado Compared to Non-medical Marijuana States: 2003-11

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2014 May 20
PMID 24837585
Citations 113
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In 2009, policy changes were accompanied by a rapid increase in the number of medical marijuana cardholders in Colorado. Little published epidemiological work has tracked changes in the state around this time.

Methods: Using the National Survey on Drug Use and Health, we tested for temporal changes in marijuana attitudes and marijuana-use-related outcomes in Colorado (2003-11) and differences within-year between Colorado and thirty-four non-medical-marijuana states (NMMS). Using regression analyses, we further tested whether patterns seen in Colorado prior to (2006-8) and during (2009-11) marijuana commercialization differed from patterns in NMMS while controlling for demographics.

Results: Within Colorado those reporting "great-risk" to using marijuana 1-2 times/week dropped significantly in all age groups studied between 2007-8 and 2010-11 (e.g. from 45% to 31% among those 26 years and older; p=0.0006). By 2010-11 past-year marijuana abuse/dependence had become more prevalent in Colorado for 12-17 year olds (5% in Colorado, 3% in NMMS; p=0.03) and 18-25 year olds (9% vs. 5%; p=0.02). Regressions demonstrated significantly greater reductions in perceived risk (12-17 year olds, p=0.005; those 26 years and older, p=0.01), and trend for difference in changes in availability among those 26 years and older and marijuana abuse/dependence among 12-17 year olds in Colorado compared to NMMS in more recent years (2009-11 vs. 2006-8).

Conclusions: Our results show that commercialization of marijuana in Colorado has been associated with lower risk perception. Evidence is suggestive for marijuana abuse/dependence. Analyses including subsequent years 2012+ once available, will help determine whether such changes represent momentary vs. sustained effects.

Citing Articles

Cannabis use in youth is associated with chronic inflammation.

Power E, Mongan D, Healy C, Susai S, Focking M, Zammit S Psychol Med. 2024; :1-11.

PMID: 39648682 PMC: 11779551. DOI: 10.1017/S0033291724002848.


Impact of Legalization on Cannabis Use, Attitudes, and Purchasing Preferences: A Repeated Cross-Sectional Survey of Canadian Young Adults.

Bradley A, Salmon M, Wohl M, Howard A Cannabis. 2024; 7(2):65-76.

PMID: 38975596 PMC: 11225976. DOI: 10.26828/cannabis/2024/000203.


Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004-2019.

Mauro P, Gutkind S, Askari M, Hasin D, Samples H, Mauro C Drug Alcohol Depend. 2024; 257():111113.

PMID: 38382162 PMC: 11736659. DOI: 10.1016/j.drugalcdep.2024.111113.


Investigating Cannabis-Use Among Students Attending High Schools Within the Cherokee Nation Reservation 2017 and 2019.

Campbell J, Chen S, Bailey A, Blair A, Comiford A J Community Health. 2023; 49(3):402-414.

PMID: 38066219 PMC: 10981585. DOI: 10.1007/s10900-023-01304-7.


Health, safety, and socioeconomic impacts of cannabis liberalization laws: An evidence and gap map.

Sevigny E, Greathouse J, Medhin D Campbell Syst Rev. 2023; 19(4):e1362.

PMID: 37915420 PMC: 10616541. DOI: 10.1002/cl2.1362.


References
1.
Thurstone C, Lieberman S, Schmiege S . Medical marijuana diversion and associated problems in adolescent substance treatment. Drug Alcohol Depend. 2011; 118(2-3):489-92. PMC: 3178678. DOI: 10.1016/j.drugalcdep.2011.03.031. View

2.
Cerda M, Wall M, Keyes K, Galea S, Hasin D . Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug Alcohol Depend. 2011; 120(1-3):22-7. PMC: 3251168. DOI: 10.1016/j.drugalcdep.2011.06.011. View

3.
Wang G, Narang S, Wells K, Chuang R . A case series of marijuana exposures in pediatric patients less than 5 years of age. Child Abuse Negl. 2011; 35(7):563-5. DOI: 10.1016/j.chiabu.2011.03.012. View

4.
Salomonsen-Sautel S, Sakai J, Thurstone C, Corley R, Hopfer C . Medical marijuana use among adolescents in substance abuse treatment. J Am Acad Child Adolesc Psychiatry. 2012; 51(7):694-702. PMC: 3381870. DOI: 10.1016/j.jaac.2012.04.004. View

5.
Wang G, Roosevelt G, Heard K . Pediatric marijuana exposures in a medical marijuana state. JAMA Pediatr. 2013; 167(7):630-3. DOI: 10.1001/jamapediatrics.2013.140. View